Corrigendum: Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance

Nature Communications 8 Article number: 14477 (2017); Published: 16 February 2017; Updated: 18 August 2017 In the References section of this Article, incorrect papers are cited for references 4, 5, 7, 9, 10, 13–20 and 29–31. In addition, in the Methods section, reference 12 should be cited instead of reference 30 following the statement ‘Immunoblot analysis was performed as we described previously’, and reference 30 should be cited instead of reference 31 following the statement ‘while plasma glucose was maintained at basal concentrations as previously described’.

[1]  V. Skulachev,et al.  Carboxyatractylate inhibits the uncoupling effect of free fatty acids , 1988, FEBS letters.

[2]  V. Skulachev,et al.  The ATP/ADP-antiporter is involved in the uncoupling effect of fatty acids on mitochondria. , 1989, European journal of biochemistry.

[3]  V. Skulachev,et al.  The ATP/ADP-antiporter is involved in the uncoupling effect of fatty acids on mitochondria. , 1989, European journal of biochemistry.

[4]  G. Rappold,et al.  A human pseudoautosomal gene, ADP/ATP translocase, escapes X–inactivation whereas a homologue on Xq is subject to X–inactivation , 1993, Nature Genetics.

[5]  D. Wallace,et al.  A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator , 1997, Nature Genetics.

[6]  A. Le Saux,et al.  The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. , 1998, Biochimie.

[7]  V. P. Chacko,et al.  Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion* , 1999, The Journal of Biological Chemistry.

[8]  S. Melov,et al.  Mitochondrial disease in mouse results in increased oxidative stress. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Wallace,et al.  Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. , 2000, Gene.

[10]  Y. Ko,et al.  Mitochondrial ATP Synthasome , 2003, The Journal of Biological Chemistry.

[11]  Theresa A. Storm,et al.  Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. , 2003, Blood.

[12]  Dean P. Jones,et al.  The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore , 2004, Nature.

[13]  M. Schlame,et al.  Characterization of lymphoblast mitochondria from patients with Barth syndrome , 2005, Laboratory Investigation.

[14]  A. Barth,et al.  Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance , 2005, International archives of occupational and environmental health.

[15]  E. Li,et al.  DNA Methylation Is Required for Silencing of Ant4, an Adenine Nucleotide Translocase Selectively Expressed in Mouse Embryonic Stem Cells and Germ Cells , 2005, Stem cells.

[16]  P. Barth,et al.  Burkitt lymphoma in a child with Joubert syndrome , 2005, Pediatric blood & cancer.

[17]  B. Byrne,et al.  Ventricular Arrhythmia in the X-linked Cardiomyopathy Barth Syndrome , 2005, Pediatric Cardiology.

[18]  M. L. Greenberg,et al.  Molecular symmetry in mitochondrial cardiolipins. , 2005, Chemistry and physics of lipids.

[19]  P. Haber,et al.  Endurance Exercise Training in Orthostatic Intolerance: A Randomized, Controlled Trial , 2005, Hypertension.

[20]  B. Cannon,et al.  Carboxyatractyloside effects on brown-fat mitochondria imply that the adenine nucleotide translocator isoforms ANT1 and ANT2 may be responsible for basal and fatty-acid-induced uncoupling respectively. , 2006, The Biochemical journal.

[21]  J. Finsterer,et al.  Acquired noncompaction in Duchenne muscular dystrophy. , 2006, International journal of cardiology.

[22]  A. Hall,et al.  The British Cardiac Society Working Group definition of myocardial infarction: implications for practice , 2005, Heart.

[23]  J. Glanville,et al.  Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. , 2006, Human reproduction.

[24]  M. Soyka,et al.  Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[25]  T. Seki,et al.  Evolutionarily Conserved Mammalian Adenine Nucleotide Translocase 4 Is Essential for Spermatogenesis* , 2007, Journal of Biological Chemistry.

[26]  M. Elliott,et al.  Successful cardiac transplantation in Barth syndrome – single‐centre experience of four patients , 2007, Pediatric transplantation.

[27]  S. Wakil,et al.  Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity , 2007, Proceedings of the National Academy of Sciences.

[28]  J. Barth,et al.  [A young fireman candidate with an abnormal chest x-ray]. , 2007, Der Internist.

[29]  W. Hwu,et al.  Mitral annuloplasty in an infant with Barth syndrome and severe mitral insufficiency: first case report and determination of annular diameter. , 2008, The Journal of thoracic and cardiovascular surgery.

[30]  M. Klingenberg.  The ADP and ATP transport in mitochondria and its carrier. , 2008, Biochimica et biophysica acta.

[31]  N. Terada,et al.  Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells. , 2009, Reproduction.

[32]  N. Chalasani,et al.  Nonalcoholic fatty liver disease and cardiovascular risk , 2009, Current gastroenterology reports.

[33]  N. Terada,et al.  Differential CpG island methylation of murine adenine nucleotide translocase genes. , 2009, Biochimica et biophysica acta.

[34]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[35]  P. Reynier,et al.  Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism. , 2011, Biochimica et biophysica acta.

[36]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[37]  G. Shulman,et al.  Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. , 2013, Cell metabolism.

[38]  M. Monné,et al.  Antiporters of the mitochondrial carrier family. , 2014, Current topics in membranes.

[39]  Jung-whan Kim,et al.  Increased Adipocyte O2 Consumption Triggers HIF-1α, Causing Inflammation and Insulin Resistance in Obesity , 2014, Cell.

[40]  G. Shulman,et al.  Niclosamide ethanolamine improves blood glycemic control and reduces hepatic steatosis in mice , 2014, Nature Medicine.

[41]  Lili Wang,et al.  Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  T. Shiratsuchi,et al.  Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesis , 2015, Cell Death and Differentiation.

[43]  Mary E Rinella,et al.  Nonalcoholic fatty liver disease: a systematic review. , 2015, JAMA.

[44]  N. Terada,et al.  Adenine Nucleotide Translocase 4 Is Expressed Within Embryonic Ovaries and Dispensable During Oogenesis , 2015, Reproductive Sciences.

[45]  Antoniya A. Aleksandrova,et al.  The transport mechanism of the mitochondrial ADP/ATP carrier. , 2016, Biochimica et biophysica acta.

[46]  X. Anguela,et al.  Adeno-associated viral vectors for the treatment of hemophilia. , 2016, Human molecular genetics.